Russell Investments Group
BMY.RT

Russell Investments Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Russell Investments Group’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,657
Closed -$137K – 3272
2020
Q4 		$137K Sell
7,657
-4,738
-38% -$10.1K ﹤0.01% 2829
2020
Q3 		$369K Hold
12,395
– – ﹤0.01% 2531
2020
Q2 		$601K Hold
12,395
– – ﹤0.01% 2309
2020
Q1 		$609K Hold
12,395
– – ﹤0.01% 2094
2019
Q4 		$515K Buy
+12,395
New +$32.2K ﹤0.01% 2385

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Russell Investments Group's BMY.RT Position: Q1 2021 in Review

Russell Investments Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 7,657 shares — an estimated $137K sold.

Russell Investments Group first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $609K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Russell Investments Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Russell Investments Group sold 7,657 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $137K.
  • Russell Investments Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Russell Investments Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $609K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Russell Investments Group's 13F filing for Q1 2021, filed 10 May 2021.